New methods for RWE collection and synthesis

Welcome to GetReal

Presentations

  • Adalsteinsson E et al, Effectiveness factors in HTA reports concerning type 2 diabetes; ISPOR 19th Annual European Congress, Vienna 29 October - 2 November, 2016

  • Ankarfeldt MZ et al, A systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs; ISPOR 19th Annual European Congress, Vienna 29 October - 2 November, 2016

  • Kalf R et al, Social media: a valuable tool to assess patient perspectives regarding quality of life; ISPOR 19th Annual European Congress, Vienna 29 October - 2 November, 2016

  • Martina R et al, Using simulated individual patient data (IPD) from published registry and IPD from the SEER-medicare registry to extrapolate results from randomised clinical trials (RCTS) in metastatic melanoma; ISPOR 19th Annual European Congress, Vienna 29 October - 2 November, 2016

  • Zuidgeest MG et al, Making pragmatic trials work; ISPOR 19th Annual European Congress, Vienna 29 October - 2 November, 2016

  • Efthimiou O et al, A general framework for exploring the impact of suboptimal treatment choices to health outcomes in a real-world population; Cochrane Colloquium Seoul, Seoul 23-27 October, 2016
  • Efthimiou O et al, Workshop: Methods for including non-randomized studies in network meta-analysis; Cochrane Colloquium Seoul, Seoul 23-27 October, 2016
  • Ankarfeldt MZ et al, Assessing channelling bias among initiators of glucose lowering drugs - A cohort study; 32nd ICPE 2016, Dublin 25-28 August, 2016
  • Ankarfeldt MZ et al, A systematic literature review on the efficacy-effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs; 32nd ICPE 2016, Dublin 25-28 August, 2016
  • Nordon C et al, Effect-modifiers of antipsychotic drufs effect, in schizophrenia treatment: preliminary results using the CGS cohort; 32nd ICPE 2016, Dublin 25-28 August, 2016
  • Jenkins D et al, Evaluating the inclusion of Real World Evidence in Network Meta-Analyses to connect disconnected networks - A Case Study in Rheumatoid Arthritis; ISCB 2016, Birmingham 21-25 August, 2016
  • Debray TPA et al, Network Meta-Analysis using Individual Participant Data: when do benefits arise?; ISCB 2016, Birmingham 21-25 August, 2016
  • Martina R et al, The use of registry data to extrapolate results from randomised clinical trials (RCTs): an example in metastatic melanoma; ISCB 2016, Birmingham 21-25 August, 2016
  • Didden E, Prediction of Treatment Effectiveness based on RCT Efficacy Data and Real-World Evidence (RWE) - A CASE STUDY ON RHEUMATOID ARTHRITIS; SRSM 11th Annual Meeting, Florence 11-13 July, 2016
  • Efthimiou O et al, Combining randomized and non-randomized evidence in a network meta-analysis; SRSM 11th Annual Meeting, Florence 11-13 July, 2016
  • Kalkman S, The Social Value of Pragmatic Trials; IAB 2016 World Congress, Edinburgh 14-17 June, 2016
  • Debray TP et al, Bridging efficacy to effectiveness: The IMI GetReal project; 2016 PSI Conference, Berlin 22-25 May, 2016
  • Didden E et al, Prediction of treatment effectiveness based on RCT efficacy data and RWE: A case study on rheumatoid arthritis; 2016 PSI Conference, Berlin 22-25 May, 2016
  • Jaksa A et al, IMI GetReal Work Package 1 Case Study: Challenges In Measuring Clinical Effectiveness In COPD And Potential Use Of Real-World Evidence To Reduce Uncertainty; ISPOR 21st Annual Meeting, Washington 21-25 May, 2016. Value in Health, 2016; 19 (3): A121-A122. DOI: 10.1016/j.jval.2016.03.488
  • Kalf R et al, Social Media: A New Tool For Collecting Effectiveness Data?; HTAi 2016 Annual Meeting, Tokyo 10-14 May, 2016
  • Makady A et al, What Is Real World Data? A Review Of Definitions Based On Literature And Stakeholder Interviews; HTAi 2016 Annual Meeting, Tokyo 10-14 May, 2016
  • Makady A et al, Real-World Data Use In Health Technology Assessment: A Policy Review; HTAi 2016 Annual Meeting, Tokyo 10-14 May, 2016
  • Meyer F et al, Real-world evidence (RWE) in drug development - creating the right environment for enhanced pre-launch evidence; DIA 28th EuroMeeting, Hamburg 6-8 April, 2016
  • Didden, E et al, Learning and predicting real-world treatment effect based on randomized controlled trials and registry data: A case study on rheumatoid arthritis; BBS Seminar, Basel 13 January, 2016
  • Jonsson P et al, Stakeholder views on the acceptability of real-worl evidence for informing trial design and assessment of relative effectiveness of new medicines; ISPOR 18th Annual European Congress, Milan 7-11 November, 2015
  • Martina R et al, The use of real world evidence (RWE) to investigate the overall treatment effects of different line of theray in Rheumatoid Arthritis; ISPOR 18th Annual European Congress, Milan 7-11 November, 2015
  • Debray T, Statistical models for network meta-analysis: an empirical comparison; 23rd Cochrane Colloquium, Vienna 3-7 October, 2015
  • Efthimiou O et al, Including observational evidence in a network meta-analysis of RCTs: a case study in schizophrenia; 23rd Cochrane Colloquium, Vienna 3-7 October, 2015
  • Martina R et al, The inclusion of real world evidence (RWE) in clinical development planning; ISCB 36th Annual Conference, Utrecht 23-27 August, 2015
  • Czachorowski M et al, Relative effectiveness challenges for multiple sclerosis therapies; HTAi 12th Annual Meeting, Oslo 15-17 June, 2015
  • Karcher H et al, Methods to Evaluate Real-World Effectiveness in Pre-Authorization Trials: A Systematic Literature Review for IMI GetReal WP2; HTAi 12th Annual Meeting, Oslo 15-17 June, 2015
  • Jonsson P, Establishing effectiveness of medicines in development; Medical Affairs Leaders Forum Spring Meeting, Berlin 26-27 February, 2015
  • Jonsson P et al, Balancing the complex requirements of key internal and external stakeholders for RWE; Medical Affairs Leaders Forum Spring Meeting, Berlin 26-27 February, 2015
  • Makady A et al, Review of Policies and Perspectives on Real-World Data for Drug Development and Assessment; WHO Collaborating Centre Winter Meeting, Utrecht 12-13 January, 2015

  • Garner S, The GetReal Project; ISPOR 17th Annual European Congress, Amsterdam 8-12 November, 2014

  • Efthimiou O et al, A multi-state Markov model for network meta-analysis of studies with missing data; ISCB 35th Annual Conference, Vienna 24-28 August, 2014

  • Van Valkenhoef G et al, Crowdsourcing a comprehensive clinical trial repository; AAAI 28th Conference, Qu├ębec 27-31 July, 2014